-
1
-
-
9444272812
-
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70
-
Albani D., Peverelli E., Rametta R., Batelli S., Veschini L., Negro A., Forloni G. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70. FASEB J 2004, 18:1713-1715.
-
(2004)
FASEB J
, vol.18
, pp. 1713-1715
-
-
Albani, D.1
Peverelli, E.2
Rametta, R.3
Batelli, S.4
Veschini, L.5
Negro, A.6
Forloni, G.7
-
2
-
-
78650505110
-
Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation
-
Anderson V.L., Ramlall T.F., Rospigliosi C.C., Webb W.W., Eliezer D. Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation. Proc Natl Acad Sci U S A 2010, 107:18850-18855.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 18850-18855
-
-
Anderson, V.L.1
Ramlall, T.F.2
Rospigliosi, C.C.3
Webb, W.W.4
Eliezer, D.5
-
4
-
-
77957347060
-
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro
-
Burré J., Sharma M., Tsetsenis T., Buchman V., Etherton M.R., Südhof T.C. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329:1663-1667.
-
(2010)
Science
, vol.329
, pp. 1663-1667
-
-
Burré, J.1
Sharma, M.2
Tsetsenis, T.3
Buchman, V.4
Etherton, M.R.5
Südhof, T.C.6
-
5
-
-
0034681163
-
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy
-
Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., Lansbury P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 2000, 97:571-576.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 571-576
-
-
Conway, K.A.1
Lee, S.J.2
Rochet, J.C.3
Ding, T.T.4
Williamson, R.E.5
Lansbury, P.T.6
-
6
-
-
0038624450
-
Parkin's substrates and the pathways leading to neuronal damage
-
Cookson M.R. Parkin's substrates and the pathways leading to neuronal damage. Neuromol Med 2003, 3:1-13.
-
(2003)
Neuromol Med
, vol.3
, pp. 1-13
-
-
Cookson, M.R.1
-
7
-
-
0141741347
-
Parkinson's disease: mechanisms and models
-
Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
8
-
-
0042521076
-
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
-
Di Monte D.A. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?. Lancet Neurol 2003, 2:531-538.
-
(2003)
Lancet Neurol
, vol.2
, pp. 531-538
-
-
Di Monte, D.A.1
-
9
-
-
0036670712
-
Aggregation and neurotoxicity of alpha-synuclein and related peptides
-
el-Agnaf O.M., Irvine G.B. Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem Soc Trans 2002, 30:559-565.
-
(2002)
Biochem Soc Trans
, vol.30
, pp. 559-565
-
-
el-Agnaf, O.M.1
Irvine, G.B.2
-
10
-
-
79952169319
-
Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD
-
Esteves A.R., Arduíno D.M., Silva D.F., Oliveira C.R., Cardoso S.M. Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD. Parkinsons Dis 2011, 2011:693-761.
-
(2011)
Parkinsons Dis
, vol.2011
, pp. 693-761
-
-
Esteves, A.R.1
Arduíno, D.M.2
Silva, D.F.3
Oliveira, C.R.4
Cardoso, S.M.5
-
11
-
-
0038727936
-
Description of Parkinson's disease as a clinical syndrome
-
Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003, 991:1-14.
-
(2003)
Ann N Y Acad Sci
, vol.991
, pp. 1-14
-
-
Fahn, S.1
-
12
-
-
77954379317
-
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
-
Garcia-Reitböck P., Anichtchik O., Bellucci A., Iovino M., Ballini C., Fineberg E., Ghetti B., Della Corte L., Spano P., Tofaris G.K., Goedert M., Spillantini M.G. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 2010, 133:2032-2044.
-
(2010)
Brain
, vol.133
, pp. 2032-2044
-
-
Garcia-Reitböck, P.1
Anichtchik, O.2
Bellucci, A.3
Iovino, M.4
Ballini, C.5
Fineberg, E.6
Ghetti, B.7
Della Corte, L.8
Spano, P.9
Tofaris, G.K.10
Goedert, M.11
Spillantini, M.G.12
-
13
-
-
68649110032
-
Mendelian forms of Parkinson's disease
-
Gasser T. Mendelian forms of Parkinson's disease. Biochim Biophys Acta 2009, 1792:587-596.
-
(2009)
Biochim Biophys Acta
, vol.1792
, pp. 587-596
-
-
Gasser, T.1
-
14
-
-
0038784529
-
Are ubiquitination pathways central to Parkinson's disease?
-
Giasson B.I., Lee V.M. Are ubiquitination pathways central to Parkinson's disease?. Cell 2003, 114:1-8.
-
(2003)
Cell
, vol.114
, pp. 1-8
-
-
Giasson, B.I.1
Lee, V.M.2
-
15
-
-
0037192865
-
Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells
-
Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., Masliah E. Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 2002, 277:11465-11472.
-
(2002)
J Biol Chem
, vol.277
, pp. 11465-11472
-
-
Hashimoto, M.1
Hsu, L.J.2
Rockenstein, E.3
Takenouchi, T.4
Mallory, M.5
Masliah, E.6
-
16
-
-
0038389601
-
Transgenic models of alpha-synuclein pathology: past, present, and future
-
Hashimoto M., Rockenstein E., Masliah E. Transgenic models of alpha-synuclein pathology: past, present, and future. Ann N Y Acad Sci 2003, 991:171-188.
-
(2003)
Ann N Y Acad Sci
, vol.991
, pp. 171-188
-
-
Hashimoto, M.1
Rockenstein, E.2
Masliah, E.3
-
17
-
-
0037237927
-
Oxidative stress and nitration in neurodegeneration: cause, effect, or association?
-
Ischiropoulos H., Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J Clin Invest 2003, 111:163-169.
-
(2003)
J Clin Invest
, vol.111
, pp. 163-169
-
-
Ischiropoulos, H.1
Beckman, J.S.2
-
18
-
-
0032500599
-
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
-
Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998, 273:26292-26294.
-
(1998)
J Biol Chem
, vol.273
, pp. 26292-26294
-
-
Jensen, P.H.1
Nielsen, M.S.2
Jakes, R.3
Dotti, C.G.4
Goedert, M.5
-
19
-
-
0037971160
-
Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity
-
Jensen P.J., Alter B.J., O'Malley K.L. Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 2003, 86:196-209.
-
(2003)
J Neurochem
, vol.86
, pp. 196-209
-
-
Jensen, P.J.1
Alter, B.J.2
O'Malley, K.L.3
-
20
-
-
79951536222
-
Alpha-synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity
-
Jin H., Kanthasamy A., Ghosh A., Yang Y., Anantharam V., Kanthasamy A.G. Alpha-synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 2011, 31:2035-2051.
-
(2011)
J Neurosci
, vol.31
, pp. 2035-2051
-
-
Jin, H.1
Kanthasamy, A.2
Ghosh, A.3
Yang, Y.4
Anantharam, V.5
Kanthasamy, A.G.6
-
21
-
-
0037137224
-
Structural and functional implications of C-terminal regions of alpha-synuclein
-
Kim T.D., Paik S.R., Yang C.H. Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 2002, 41:13782-13790.
-
(2002)
Biochemistry
, vol.41
, pp. 13782-13790
-
-
Kim, T.D.1
Paik, S.R.2
Yang, C.H.3
-
22
-
-
0034492520
-
Structural changes in alpha-synuclein affect its chaperone-like activity in vitro
-
Kim T.D., Paik S.R., Yang C.H., Kim J. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 2000, 9:2489-2496.
-
(2000)
Protein Sci
, vol.9
, pp. 2489-2496
-
-
Kim, T.D.1
Paik, S.R.2
Yang, C.H.3
Kim, J.4
-
23
-
-
0031990490
-
Ala30-to-pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
-
Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30-to-pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998, 18:106-108.
-
(1998)
Nat Genet
, vol.18
, pp. 106-108
-
-
Krüger, R.1
Kuhn, W.2
Müller, T.3
Woitalla, D.4
Graeber, M.5
Kösel, S.6
Przuntek, H.7
Epplen, J.T.8
Schöls, L.9
Riess, O.10
-
24
-
-
77957371012
-
Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection
-
Lee H.J., Kim C., Lee S.J. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxid Med Cell Longev 2010, 3:283-287.
-
(2010)
Oxid Med Cell Longev
, vol.3
, pp. 283-287
-
-
Lee, H.J.1
Kim, C.2
Lee, S.J.3
-
25
-
-
0042477558
-
Alpha-synuclein and presynaptic function: implications for Parkinson's disease
-
Lykkebo S., Jensen P.H. Alpha-synuclein and presynaptic function: implications for Parkinson's disease. Neuromol Med 2002, 2:115-129.
-
(2002)
Neuromol Med
, vol.2
, pp. 115-129
-
-
Lykkebo, S.1
Jensen, P.H.2
-
26
-
-
0038334899
-
Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration
-
Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 2003, 23:3095-3099.
-
(2003)
J Neurosci
, vol.23
, pp. 3095-3099
-
-
Manning-Bog, A.B.1
McCormack, A.L.2
Purisai, M.G.3
Bolin, L.M.4
Di Monte, D.A.5
-
27
-
-
0038711511
-
Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications
-
Norris E.H., Giasson B.I., Ischiropoulos H., Lee V.M. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem 2003, 278:27230-27240.
-
(2003)
J Biol Chem
, vol.278
, pp. 27230-27240
-
-
Norris, E.H.1
Giasson, B.I.2
Ischiropoulos, H.3
Lee, V.M.4
-
28
-
-
79953236488
-
Synuclein modulation of monoamine transporters
-
Oaks A.W., Sidhu A. Synuclein modulation of monoamine transporters. FEBS Lett 2011, 585:1001-1006.
-
(2011)
FEBS Lett
, vol.585
, pp. 1001-1006
-
-
Oaks, A.W.1
Sidhu, A.2
-
29
-
-
0033565874
-
Alpha-synuclein shares physical and functional homology with 14-3-3 proteins
-
Osterova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., Wolozin B. Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 1999, 19:5782-5791.
-
(1999)
J Neurosci
, vol.19
, pp. 5782-5791
-
-
Osterova, N.1
Petrucelli, L.2
Farrer, M.3
Mehta, N.4
Choi, P.5
Hardy, J.6
Wolozin, B.7
-
30
-
-
0037047371
-
Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone
-
Park S.M., Jung H.Y., Kim T.D., Park J.H., Yang C.H., Kim J. Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone. J Biol Chem 2002, 277:28512-28520.
-
(2002)
J Biol Chem
, vol.277
, pp. 28512-28520
-
-
Park, S.M.1
Jung, H.Y.2
Kim, T.D.3
Park, J.H.4
Yang, C.H.5
Kim, J.6
-
31
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
Ide, S.E.4
Dehejia, A.5
Dutra, A.6
Pike, B.7
Root, H.8
Rubenstein, J.9
Boyer, R.10
Stenroos, E.S.11
Chandrasekharappa, S.12
Athanassiadou, A.13
Papapetropoulos, T.14
Johnson, W.G.15
Lazzarini, A.M.16
Duvoisin, R.C.17
Di Iorio, G.18
Golbe, L.I.19
Nussbaum, R.L.20
more..
-
32
-
-
79955807710
-
Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress
-
Riedel M., Goldbaum O., Wille M., Richter-Landsberg C. Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. J Mol Neurosci 2011, 43:290-302.
-
(2011)
J Mol Neurosci
, vol.43
, pp. 290-302
-
-
Riedel, M.1
Goldbaum, O.2
Wille, M.3
Richter-Landsberg, C.4
-
33
-
-
0032192146
-
Recent advances in inducible gene expression systems
-
Rossi F.M., Blau H.M. Recent advances in inducible gene expression systems. Curr Opin Biotechnol 1998, 9:451-456.
-
(1998)
Curr Opin Biotechnol
, vol.9
, pp. 451-456
-
-
Rossi, F.M.1
Blau, H.M.2
-
34
-
-
11144353869
-
Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons
-
Saha A.R., Hill J., Utton M.A., Asuni A.A., Ackerley S., Grierson A.J., Miller C.C., Davies A.M., Buchman V.L., Anderton B.H., Hanger D.P. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci 2004, 117:1017-1724.
-
(2004)
J Cell Sci
, vol.117
, pp. 1017-1724
-
-
Saha, A.R.1
Hill, J.2
Utton, M.A.3
Asuni, A.A.4
Ackerley, S.5
Grierson, A.J.6
Miller, C.C.7
Davies, A.M.8
Buchman, V.L.9
Anderton, B.H.10
Hanger, D.P.11
-
35
-
-
77953796839
-
A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration
-
Scott D.A., Tabarean I., Tang Y., Cartier A., Masliah E., Roy S. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci 2010, 30:8083-8095.
-
(2010)
J Neurosci
, vol.30
, pp. 8083-8095
-
-
Scott, D.A.1
Tabarean, I.2
Tang, Y.3
Cartier, A.4
Masliah, E.5
Roy, S.6
-
36
-
-
0036832421
-
Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway
-
Seo J.H., Rah J.C., Choi S.H., Shin J.K., Min K., Kim H.S., Park C.H., Kim S., Kim E.M., Lee S.H., Lee S., Suh S.W., Suh Y.H. Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J 2002, 16:1826-1828.
-
(2002)
FASEB J
, vol.16
, pp. 1826-1828
-
-
Seo, J.H.1
Rah, J.C.2
Choi, S.H.3
Shin, J.K.4
Min, K.5
Kim, H.S.6
Park, C.H.7
Kim, S.8
Kim, E.M.9
Lee, S.H.10
Lee, S.11
Suh, S.W.12
Suh, Y.H.13
-
37
-
-
0037229425
-
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
-
Sherer T.B., Kim J.H., Betarbet R., Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003, 179:9-16.
-
(2003)
Exp Neurol
, vol.179
, pp. 9-16
-
-
Sherer, T.B.1
Kim, J.H.2
Betarbet, R.3
Greenamyre, J.T.4
-
38
-
-
0242300619
-
Alpha-synuclein locus triplication causes Parkinson's disease
-
Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
Singleton, A.4
Hague, S.5
Kachergus, J.6
Hulihan, M.7
Peuralinna, T.8
Dutra, A.9
Nussbaum, R.10
Lincoln, S.11
Crawley, A.12
Hanson, M.13
Maraganore, D.14
Adler, C.15
Cookson, M.R.16
Muenter, M.17
Baptista, M.18
Miller, D.19
Blancato, J.20
Hardy, J.21
Gwinn-Hardy, K.22
more..
-
39
-
-
70349503591
-
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein
-
Uversky V.N., Eliezer D. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 2009, 10:483-499.
-
(2009)
Curr Protein Pept Sci
, vol.10
, pp. 483-499
-
-
Uversky, V.N.1
Eliezer, D.2
-
40
-
-
53049098471
-
Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells
-
Vogiatzi T., Xilouri M., Vekrellis K., Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008, 283:23542-23556.
-
(2008)
J Biol Chem
, vol.283
, pp. 23542-23556
-
-
Vogiatzi, T.1
Xilouri, M.2
Vekrellis, K.3
Stefanis, L.4
-
41
-
-
0038386274
-
Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease
-
Volles M.J., Lansbury P.T. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 2003, 42:7871-7878.
-
(2003)
Biochemistry
, vol.42
, pp. 7871-7878
-
-
Volles, M.J.1
Lansbury, P.T.2
-
42
-
-
0037379324
-
Genetic and environmental factors in the cause of Parkinson's disease
-
Warner T.T., Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 2003, 53(Suppl 3):S16-S23.
-
(2003)
Ann Neurol
, vol.53
, Issue.SUPPL 3
-
-
Warner, T.T.1
Schapira, A.H.2
-
43
-
-
0141726844
-
Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity
-
Wersinger C., Prou D., Vernier P., Niznik H.B., Sidhu A. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol Cell Neurosci 2003, 24:91-105.
-
(2003)
Mol Cell Neurosci
, vol.24
, pp. 91-105
-
-
Wersinger, C.1
Prou, D.2
Vernier, P.3
Niznik, H.B.4
Sidhu, A.5
-
44
-
-
77957189194
-
α-Synuclein impairs macroautophagy: implications for Parkinson's disease
-
Winslow A.R., Chen C.W., Corrochano S., Acevedo-Arozena A., Gordon D.E., Peden A.A., Lichtenberg M., Menzies F.M., Ravikumar B., Imarisio S., Brown S., O'Kane C.J., Rubinsztein D.C. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010, 190:1023-1037.
-
(2010)
J Cell Biol
, vol.190
, pp. 1023-1037
-
-
Winslow, A.R.1
Chen, C.W.2
Corrochano, S.3
Acevedo-Arozena, A.4
Gordon, D.E.5
Peden, A.A.6
Lichtenberg, M.7
Menzies, F.M.8
Ravikumar, B.9
Imarisio, S.10
Brown, S.11
O'Kane, C.J.12
Rubinsztein, D.C.13
-
45
-
-
77956596883
-
Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
-
Xie W., Li X., Li C., Zhu W., Jankovic J., Le W. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem 2010, 115:188-199.
-
(2010)
J Neurochem
, vol.115
, pp. 188-199
-
-
Xie, W.1
Li, X.2
Li, C.3
Zhu, W.4
Jankovic, J.5
Le, W.6
-
46
-
-
65849127844
-
Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy
-
Xilouri M., Vogiatzi T., Vekrellis K., Park D., Stefanis L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009, 4(5):e5515.
-
(2009)
PLoS One
, vol.4
, Issue.5
-
-
Xilouri, M.1
Vogiatzi, T.2
Vekrellis, K.3
Park, D.4
Stefanis, L.5
-
47
-
-
53549118274
-
Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis
-
Xilouri M., Vogiatzi T., Vekrellis K., Stefanis L. Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy 2008, 4:917-919.
-
(2008)
Autophagy
, vol.4
, pp. 917-919
-
-
Xilouri, M.1
Vogiatzi, T.2
Vekrellis, K.3
Stefanis, L.4
-
48
-
-
58149215720
-
Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy
-
Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., Mao Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323:124-127.
-
(2009)
Science
, vol.323
, pp. 124-127
-
-
Yang, Q.1
She, H.2
Gearing, M.3
Colla, E.4
Lee, M.5
Shacka, J.J.6
Mao, Z.7
-
49
-
-
80051591601
-
C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells
-
Yin J., Han J., Zhang C., Ma Q.L., Li X., Cheng F., Liu G., Li Y., Uéda K., Chan P., Yu S. C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells. J Neural Transm 2011, 118:1155-1164.
-
(2011)
J Neural Transm
, vol.118
, pp. 1155-1164
-
-
Yin, J.1
Han, J.2
Zhang, C.3
Ma, Q.L.4
Li, X.5
Cheng, F.6
Liu, G.7
Li, Y.8
Uéda, K.9
Chan, P.10
Yu, S.11
-
50
-
-
10744230149
-
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
-
Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., del Ser T., Muñoz D.G., de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004, 55:164-173.
-
(2004)
Ann Neurol
, vol.55
, pp. 164-173
-
-
Zarranz, J.J.1
Alegre, J.2
Gómez-Esteban, J.C.3
Lezcano, E.4
Ros, R.5
Ampuero, I.6
Vidal, L.7
Hoenicka, J.8
Rodriguez, O.9
Atarés, B.10
Llorens, V.11
Gomez Tortosa, E.12
del Ser, T.13
Muñoz, D.G.14
de Yebenes, J.G.15
|